Latest Breaking News On - Arcadia securities - Page 8 : comparemela.com

Form S-1/A iBio, Inc

Form S-1/A iBio, Inc
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesNew yorkLincoln parkNew jerseyState of delawareDistrict of columbiaFelipe duranEvert schimmelpenninkJamest hillAlexandra kropotovaLeslie marlowWilliam clarkPatrickj eganMartin brennerHank gracin

Quetta Acquisition Corporation Announces Closing of $69 Million Initial Public Offering

Quetta Acquisition Corporation Announces Closing of $69 Million Initial Public Offering
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesHong kongCorporationhui chenchairmanArcadia securitiesInvestments llc ef huttonSyndicate departmentExchange commission onRobinson coleQuetta acquisition corporationAcquisition corporationNasdaq global marketBenchmark investmentsCapital marketsExchange commissionQuetta acquisition corporationhui chenchairman

Quetta Acquisition Corporation Announces Pricing of $60 Million Initial Public Offering

05.10.2023 - NEW YORK, Oct. 05, 2023 (GLOBE NEWSWIRE) - Quetta Acquisition Corporation (NASDAQ: QETAU, the Company ) announced today that it priced its initial public offering of 6,000,000 units at $10.00 per unit. The units are expected to be listed on the .

Quetta acquisition corporationArcadia securitiesAcquisition corporationNasdaq global marketBenchmark investmentsCapital markets

SAB Biotherapeutics (SABS) Announces Private Placement of up to $130 Million

SAB Biotherapeutics (SABS) Announces Private Placement of up to $130 Million
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesRaymond jamesEddie sullivanMarshall waceAndrew moinExchange commissionRd fundCompany board of directors theArcadia securitiesSessa capitalCommodore capitalChief executive officerManaging directorCapital marketsSecurities act

SAB Biotherapeutics Announces Private Placement of up to $130 Million to Advance Development of Lead Drug Candidate for Type 1 Diabetes

Funding to support clinical advancement of SAB-142, a potential disease-modifying treatment Financing led by RA Capital Management, with participation from BVF Partners, Sessa Capital, Commodore.

United statesRaymond jamesAndrew moinMarshall waceEddie sullivanArcadia securitiesRd fundBiotherapeutics incExchange commissionCompany board of directors theSessa capitalCommodore capitalChief executive officerManaging directorCapital marketsSecurities act